SCHEMBL8910544

SCHEMBL8910544

O=[C]C(c1ccncc1)c1ccncc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 1/20 0.41
CYP19A1 P11511 2/20 0.39
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HDAC8 Q9BY41 2/20 0.35
CYP17A1 P05093 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910189 0.91 SLC6A3 (0.58) SLC6A2SLC6A4SLC6A3MAPTLMNA
SCHEMBL6699392 0.75 CYP3A4 (0.43) SLC6A2SLC6A4SLC6A3CYP3A4CYP2C19
SCHEMBL10997123 0.75 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3CYP3A4CYP2C19
SCHEMBL8910732 0.72 CFTR (0.57) SLC6A2SLC6A4SLC6A3CYP19A1KDM4E
SCHEMBL8911618 0.72 CFTR (0.52) SLC6A2SLC6A4SLC6A3CYP3A4CYP19A1
SCHEMBL10590199 0.72 CYP3A4 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4CYP2C19
SCHEMBL1992891 0.70 CYP3A4 (0.39) SLC6A2SLC6A4SLC6A3CYP3A4CYP2C19
SCHEMBL8472664 0.69 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP3A4CYP2C19
SCHEMBL3335587 0.68 TSHR (0.44) CYP3A4CYP2C19CYP19A1LMNAALDH1A1
SCHEMBL8909503 0.68 LMNA (0.48) LMNAHDAC8ALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed